MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers Meeting Abstract
| Authors: | Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; Lipson, D.; de Stanchina, E.; Davare, M.; Miller, V. A.; Riely, G. J.; Rudin, C. M.; Kris, M. G.; Cheng, E.; Ladanyi, M.; Drilon, A. E. |
| Abstract Title: | MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 472s |
| Language: | English |
| ACCESSION: | WOS:000404711506214 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9068 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9068 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
